Impact of maternal serum levels of Visfatin, AFP, PAPP-A, sFlt-1 and PlGF at 11–13 weeks gestation on small for gestational age births

Autor: J Fryze, Stefanie Frölich, Markus Schmidt, Angela Köninger, Alexandra Gellhaus, Rainer Kimmig, Börge Schmidt, Cahit Birdir
Rok vydání: 2016
Předmět:
Adult
medicine.medical_specialty
Pregnancy-associated plasma protein A
Medizin
Enzyme-Linked Immunosorbent Assay
Gestational Age
030204 cardiovascular system & hematology
Ultrasonography
Prenatal

Young Adult
03 medical and health sciences
0302 clinical medicine
Pregnancy
Interquartile range
Internal medicine
Odds Ratio
medicine
Humans
Pregnancy-Associated Plasma Protein-A
Nicotinamide Phosphoribosyltransferase
Retrospective Studies
030219 obstetrics & reproductive medicine
business.industry
Obstetrics
Smoking
Infant
Newborn

Membrane Proteins
Obstetrics and Gynecology
Gestational age
Odds ratio
medicine.disease
Confidence interval
Pregnancy Trimester
First

Logistic Models
Endocrinology
ROC Curve
Case-Control Studies
Infant
Small for Gestational Age

Pediatrics
Perinatology and Child Health

Small for gestational age
Gestation
Female
business
Biomarkers
Zdroj: The Journal of Maternal-Fetal & Neonatal Medicine. 30:629-634
ISSN: 1476-4954
1476-7058
Popis: Investigating potential value of maternal serum Visfatin, sFlt-1, PlGF, AFP, PAPP-A levels at first trimester for prediction of small for gestational age (SGA) at birth.Measurements were performed in 20 SGA and 65 control cases. Logistic regression analysis adjusted for age and weeks of pregnancy at data collection was performed to estimate odds ratios (OR), 95% confidence intervals (95% CI) and p values separately for each potential predictor. A multiple regression model was used to assess the impact of all the promising predictors adjusted for each other. Receiver operating characteristic (ROC) analysis was used to indicate the ability to discriminate between SGA cases and controls.There was an association of serum PlGF levels (OR 0.53 per interquartile range [IQR] increase in PlGF; 95% CI 0.24-1.16), sFlt-1/PlGF ratio (OR 1.42 per IQR increase in sFlt-1/PlGF; 95% CI 1.03-1.96), serum Visfatin levels (OR 0.31 per IQR increase in Visfatin; 95% CI 0.10-0.95) and smoking (OR 4.24; 95% CI 1.10-16.37) with SGA at birth.Associations between SGA and lower PlGF, Visfatin levels as well as increased sFlt-1/PlGF ratio and smoking status were detected which may contribute to predict SGA.
Databáze: OpenAIRE